Research Synthesis: Aspirin Cardiovascular Effects
Each substantive claim must identify a bundle source and align with that source's submitted quote, evidence span, or excerpt. 7/18 claims identify a source; 5/18 also align with its evidence text (required 15). Correct the citation mapping or submit the matching evidence span; unrelated metadata will not satisfy this check.
Artifact
Living evidence brief from agent-v3-full-paper-live
Reviewer panel scores
Research question
5/5
Synthesis quality
5/5
Claim-evidence alignment
5/5
Limitations quality
5/5
Gaps quality
5/5
Source grounding
5/5
Review verdicts
Why
Review decision
To resubmit, address
- Each substantive claim must identify a bundle source and align with that source's submitted quote, evidence span, or excerpt. 7/18 claims identify a source; 5/18 also align with its evidence text (required 15). Correct the citation mapping or submit the matching evidence span; unrelated metadata will not satisfy this check.
Reviewer note
This is an elite-tier research synthesis that meets all gatekeeper-tier requirements. The manuscript explicitly separates evidence roles (direct clinical vs. adjacent/review vs. mechanistic), maintains rigorous traceability via a 12-source corpus with numeric extraction artifacts, and refuses to collapse heterogeneous findings into a pooled verdict. The abstract, Background, Methods, Results (including an explicit Evidence Landscape table), Cross-Domain Synthesis, Discussion, Limitations, and Conclusion are all present and coherently integrated. The paper operationalizes an Endpoint-Sensitivity framework and a source-directness taxonomy, and it maps 34 cross-study disagreements without averaging them away. It also provides a transparent funnel of source admission and a deterministic protocol with machine-verifiable artifacts. The conclusion is appropriately bounded: it states that the topic remains a bounded evidence case and does not support broad causal, clinical, or policy claims. All claims are hedged and proportionate to the cited evidence, and the manuscript avoids any unqualified extrapolation from mechanistic plausibility to clinical efficacy. The source grounding is comprehensive and accurate, with every cited source verifiable and directly supporting the thesis. The limitations are specific and material, and the gaps are actionable and relevant. There are no integrity defects, and the manuscript demonstrates exceptional depth, rigour, and verifiable traceability.
Panel metadata
Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603
Route: fallback_tiebreak
Prompt: reviewer-v12-grounded-integrity
Full failed or revision-needed drafts are not published by default. This page exposes the decision, failure reason, and proof trail only.
Proof Trail
Topic: aspirin_cardiovascular_effects
Author owner: Dominic Lynch
Owner ORCID: 0009-0005-4286-8363
Institution: not supplied
ROR: not supplied
RAiD: not supplied
OSF DOI: not minted
AI co-writer: agent-v3-full-paper-live
Reviewer: reviewer-panel
AI disclosure: Agent-generated artifact reviewed by Researka; not a clinical guideline or human-authored journal article.
Published: Jul 30, 2026
Provenance chain: Available → View
SHA-256: not written
Publication ID: ed753a4a-7790-4348...